查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1668701

2025 年伤口护理生技药品全球市场报告

Wound Care Biologics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年伤口护理生技药品市场规模将强劲成长。到 2029 年，这一数字将成长至 29.6 亿美元，复合年增长率为 9.2%。预测期内的成长可归因于对个人化医疗的关注、不断增加的医疗支出、基于价值的医疗保健模式、对先进疗法的不断增长的需求以及监管支持和核准。预测期内的关键趋势包括关注再生医学、生物工程皮肤替代、创新的输送系统、增加慢性伤口管理和以患者为中心的护理。

预计糖尿病盛行率的不断上升将在不久的将来推动伤口护理生技药品市场的成长。糖尿病是一种慢性代谢疾病，其特征是血糖值升高，随着时间的推移会对心臟、血管、眼睛、肾臟和神经造成严重损害。生物创伤护理产品可防止过多的液体流失、热量流失以及蛋白质和电解质流失，同时最大限度地减少污染。促进自溶脱屑，促进颗粒状伤口层的形成。糖尿病高盛行率是推动伤口护理生技药品市场成长的关键因素。例如，2024 年 6 月，英国政府部门国家医疗服务体系 (NHS) 报告称，40 岁以下患有糖尿病的人数有所增加，从 2022 年的 173,166 人增加到 2023 年的 216,440 人。这一显着增长表明该年龄层的趋势令人不安，凸显了年轻人中糖尿病盛行率的快速上升。因此，糖尿病的高盛行率正在推动伤口护理生技药品市场的扩张。

预计外科手术的增加将推动伤口护理生技药品市场未来的成长。外科手术包括需要切口和使用器械治疗病人病情的医疗介入。伤口护理生技药品通常含有活细胞、生长因子和其他促进自然癒合过程的生物材料。随着外科手术数量的增加，人们对能够加速伤口癒合、减少併发症和改善患者整体预后的先进创伤护理解决方案的兴趣也在增加。例如，总部位于法国的政府间经济合作暨发展组织在 2023 年 10 月报告称，捷克共和国的白内障手术数量将增加 8.4%，从 2021 年的 131,612 例增至 2022 年的 142,670 例。因此，手术数量的增加正在推动伤口护理生技药品市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球伤口护理生技药品PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球伤口护理生技药品市场：成长率分析
  • 全球伤口护理生技药品市场表现：规模与成长，2019 年至 2024 年
  • 全球伤口护理生技药品市场预测：2024-2029 年及 2034 年规模与成长
  • 伤口护理生技药品的全球总目标市场 (TAM)

第六章 市场细分

  • 全球伤口护理生技药品市场（依产品、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 生物皮肤替代品
  • 外用药物
  • 全球伤口护理生技药品市场（按伤口类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 溃疡
  • 外科手术
  • 创伤
  • 烧伤
  • 全球伤口护理生技药品市场（按最终用户划分）、历史数据和预测（2019-2024 年、2024-2029 年、2034 年）
  • 医院
  • 门诊手术中心（ACS）
  • 烧烫伤中心
  • 伤口诊所
  • 全球伤口护理生技药品市场，依生物皮肤替代品类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 去细胞真皮基质
  • 细胞皮肤替代品
  • 复合皮肤替代品
  • 全球伤口护理生技药品市场，依局部药物类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 生长因子
  • 抗菌剂
  • 酵素清创剂

第七章 区域和国家分析

  • 全球伤口护理生技药品市场各地区状况、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球伤口护理生技药品市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年预测、2034 年预测）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 伤口护理生技药品市场：竞争格局
  • 伤口护理生技药品市场：公司简介
    • Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
    • MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Kerecis AG
  • Amnio Technology LLC
  • Anika Therapeutics Inc.
  • ACell Inc.
  • Derma Sciences Inc.
  • Soluble Systems Pvt. Ltd.
  • Medline Industries LP
  • Solsys Medical LLC
  • Zimmer Biomet Holdings Inc.
  • MLM Biologics Inc.
  • Tissue Genesis LLC
  • Stryker Corporation
  • Marine Polymer Technologies Inc.
  • Bioventus Inc.
  • Molnlycke Health Care AB

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年伤口护理生技药品市场：提供新机会的国家
  • 2029 年伤口护理生技药品市场：提供新机会的细分市场
  • 伤口护理生技药品市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r24609

Wound care biologics refer to bioengineered products specifically designed for the treatment of non-healing wounds in the lower extremity. These biologics are gaining prominence in wound care due to their effective control of secretions and protective properties against bacterial infections.

The primary products within the field of wound care biologics include biologic skin substitutes and topical agents. Biologic skin substitutes play a crucial role in wound healing and have proven to be highly beneficial within the medical industry. Also known as tissue-engineered products or artificial skin, biologic skin substitutes are biological substances that facilitate wound healing by promoting the generation of new tissues. Wound care biologics are commonly utilized to treat various types of wounds, including ulcers, surgical wounds, traumatic wounds, and burns. The end users of these biologics include hospitals, Ambulatory Surgical Centers (ASCs), burn centers, and wound clinics.

The wound care biologics software market research report is one of a series of new reports from The Business Research Company that provides wound care biologics software market statistics, including wound care biologics software industry global market size, regional shares, competitors with a wound care biologics software market share, detailed wound care biologics software market segments, market trends and opportunities, and any further data you may need to thrive in the wound care biologics software industry. This wound care biologics software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wound care biologics market size has grown strongly in recent years. It will grow from$1.91 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to clinical evidence and studies, regulatory framework development, wound care market evolution, limited treatment options, research and development efforts

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to focus on personalized medicine, rise in healthcare expenditure, value-based healthcare models, growing demand for advanced therapies, regulatory support and approvals. Major trends in the forecast period include regenerative medicine emphasis, bioengineered skin substitutes, innovative delivery systems, rise in chronic wound management, patient-centric care.

The increasing prevalence of diabetes is expected to drive the growth of the wound care biologics market in the near future. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels, which can lead to severe damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care products help prevent excessive water loss, heat loss, and the loss of proteins and electrolytes, while also minimizing contamination. They facilitate autolytic debridement and promote the formation of a granular wound layer. The high prevalence of diabetes is a key factor contributing to the growth of the wound care biologics market. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, reported an increase in diabetes cases among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth indicates a troubling trend in this age group and highlights the rapid rise in diabetes prevalence among younger populations. Thus, the high prevalence of diabetes is driving the expansion of the wound care biologics market.

The rising number of surgical procedures is expected to drive the growth of the wound care biologics market in the future. Surgical procedures involve medical interventions that require incisions or the use of instruments to treat a patient's medical condition. Wound care biologics typically include living cells, growth factors, or other biological materials that promote the natural healing process. As the volume of surgical procedures increases, so does the interest in advanced wound care solutions that can expedite the healing of surgical wounds, reduce complications, and improve overall patient outcomes. For example, in October 2023, the Organization for Economic Co-operation and Development, a France-based intergovernmental organization, reported an 8.4% increase in cataract surgeries in the Czech Republic, with a total of 142,670 procedures in 2022, up from 131,612 in 2021. Thus, the increase in surgical procedures is fueling the growth of the wound care biologics market.

Major companies in the wound care biologics market are concentrating on developing advanced materials, such as bioengineered, electrospun synthetic polymer matrices, to improve wound healing efficacy and support tissue regeneration. These bioengineered matrices facilitate faster wound healing and enhanced tissue regeneration by acting as scaffolds that encourage cellular migration and growth. For example, in October 2024, Royal Biologics, a US-based orthobiologics and life sciences company, introduced two innovative products at the symposium on advanced wound care: the Peak Powder Collagen Matrix, which enhances healing in various wounds by creating a gel-like barrier that supports tissue regeneration, and ElectroFiber 3D, a bioengineered matrix that promotes cellular migration and reduces healing times. These advancements significantly influence the wound care biologics market by addressing the increasing demand for effective healing solutions.

Skin graft development is a major focus for key companies in the wound care biologics market, aiming to gain a competitive edge. Skin grafting involves a surgical procedure where healthy skin is transplanted from one body area (donor site) to another area that has lost its protective covering due to injury, surgery, burns, or other traumatic conditions. For instance, in July 2022, Tides Medical, a US-based biotechnology company, launched Artacent AC, a tri-layer skin graft designed for treating complex or challenging wounds. With a three-layer structure (amnion-chorion-amnion), it surpasses traditional dual-layer products, being three times stronger and two times thicker. Artacent AC is developed to enhance handling and application to wound sites, offering clinicians an improved solution for complex patient wounds in various medical conditions such as diabetic foot ulcers, chronic wounds, burns, Mohs surgery, and other surgical applications. The product boasts a longer shelf life at room temperature, eliminating the need for refrigeration, and can be placed on either side facing the wound.

In July 2023, Coloplast, a US-based healthcare company, acquired Kerecis for $1.3 billion. Through this acquisition, Coloplast aims to strengthen its presence in the advanced wound care market by integrating Kerecis's innovative fish skin technology. This move helps Coloplast enter the high-growth U.S. biologics sector, enhance its revenue and gross margins, and raise its long-term organic growth guidance from 7% to 9% to 8% to 10%, all while allowing Kerecis to operate as a standalone business unit. Kerecis is an Iceland-based company specializing in regenerative medicine solutions using fish skin to treat chronic wounds and surgical applications.

Major companies operating in the wound care biologics market include Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Molnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

North America was the largest region in the wound care biologics market in 2024. Asia-pacific is expected to be the fastest-growing region in the global wound care biologics market report during the forecast period. The regions covered in the wound care biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wound care biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The wound care biologics market consists of revenues earned by entities by providing wound care services such as surgical and traumatic wounds, burns chronic wounds and acute Wounds. The market value includes the value of related goods sold by the service provider or included within the service offering. The wound care biologics market also includes sales of surgical equipment's, medical tape, sponges, cotton pads which are used in providing wound care biologics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wound Care Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wound care biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wound care biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wound care biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Biologic Skin Substitutes; Topical Agents
  • 2) By Wound Type: Ulcers; Surgical; Traumatic Wounds; Burns
  • 3) By End User: Hospitals; Ambulatory Surgery Center (ACS); Burn Centers; Wound Clinics
  • Subsegments:
  • 1) By Biologic Skin Substitutes: Acellular Dermal Matrices; Cellular Skin Substitutes; Composite Skin Substitutes
  • 2) By Topical Agents: Growth Factors; Antimicrobial Agents; Enzymatic Debridement Agents
  • Companies Mentioned: Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wound Care Biologics Market Characteristics

3. Wound Care Biologics Market Trends And Strategies

4. Wound Care Biologics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Wound Care Biologics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wound Care Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wound Care Biologics Market Growth Rate Analysis
  • 5.4. Global Wound Care Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wound Care Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wound Care Biologics Total Addressable Market (TAM)

6. Wound Care Biologics Market Segmentation

  • 6.1. Global Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologic Skin Substitutes
  • Topical Agents
  • 6.2. Global Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ulcers
  • Surgical
  • Traumatic Wounds
  • Burns
  • 6.3. Global Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgery Center (ACS)
  • Burn Centers
  • Wound Clinics
  • 6.4. Global Wound Care Biologics Market, Sub-Segmentation Of Biologic Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acellular Dermal Matrices
  • Cellular Skin Substitutes
  • Composite Skin Substitutes
  • 6.5. Global Wound Care Biologics Market, Sub-Segmentation Of Topical Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors
  • Antimicrobial Agents
  • Enzymatic Debridement Agents

7. Wound Care Biologics Market Regional And Country Analysis

  • 7.1. Global Wound Care Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wound Care Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wound Care Biologics Market

  • 8.1. Asia-Pacific Wound Care Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wound Care Biologics Market

  • 9.1. China Wound Care Biologics Market Overview
  • 9.2. China Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wound Care Biologics Market

  • 10.1. India Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wound Care Biologics Market

  • 11.1. Japan Wound Care Biologics Market Overview
  • 11.2. Japan Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wound Care Biologics Market

  • 12.1. Australia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wound Care Biologics Market

  • 13.1. Indonesia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wound Care Biologics Market

  • 14.1. South Korea Wound Care Biologics Market Overview
  • 14.2. South Korea Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wound Care Biologics Market

  • 15.1. Western Europe Wound Care Biologics Market Overview
  • 15.2. Western Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wound Care Biologics Market

  • 16.1. UK Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wound Care Biologics Market

  • 17.1. Germany Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wound Care Biologics Market

  • 18.1. France Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wound Care Biologics Market

  • 19.1. Italy Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wound Care Biologics Market

  • 20.1. Spain Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wound Care Biologics Market

  • 21.1. Eastern Europe Wound Care Biologics Market Overview
  • 21.2. Eastern Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wound Care Biologics Market

  • 22.1. Russia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wound Care Biologics Market

  • 23.1. North America Wound Care Biologics Market Overview
  • 23.2. North America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wound Care Biologics Market

  • 24.1. USA Wound Care Biologics Market Overview
  • 24.2. USA Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wound Care Biologics Market

  • 25.1. Canada Wound Care Biologics Market Overview
  • 25.2. Canada Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wound Care Biologics Market

  • 26.1. South America Wound Care Biologics Market Overview
  • 26.2. South America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wound Care Biologics Market

  • 27.1. Brazil Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wound Care Biologics Market

  • 28.1. Middle East Wound Care Biologics Market Overview
  • 28.2. Middle East Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wound Care Biologics Market

  • 29.1. Africa Wound Care Biologics Market Overview
  • 29.2. Africa Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wound Care Biologics Market Competitive Landscape And Company Profiles

  • 30.1. Wound Care Biologics Market Competitive Landscape
  • 30.2. Wound Care Biologics Market Company Profiles
    • 30.2.1. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Wound Care Biologics Market Other Major And Innovative Companies

  • 31.1. Kerecis AG
  • 31.2. Amnio Technology LLC
  • 31.3. Anika Therapeutics Inc.
  • 31.4. ACell Inc.
  • 31.5. Derma Sciences Inc.
  • 31.6. Soluble Systems Pvt. Ltd.
  • 31.7. Medline Industries LP
  • 31.8. Solsys Medical LLC
  • 31.9. Zimmer Biomet Holdings Inc.
  • 31.10. MLM Biologics Inc.
  • 31.11. Tissue Genesis LLC
  • 31.12. Stryker Corporation
  • 31.13. Marine Polymer Technologies Inc.
  • 31.14. Bioventus Inc.
  • 31.15. Molnlycke Health Care AB

32. Global Wound Care Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wound Care Biologics Market

34. Recent Developments In The Wound Care Biologics Market

35. Wound Care Biologics Market High Potential Countries, Segments and Strategies

  • 35.1 Wound Care Biologics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wound Care Biologics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wound Care Biologics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer